FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
chloramphénicol 1 g, fiole de poudre pour injection (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
chloramphénicol 1 g, fiole de poudre pour injection (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Deferoxamine mesylate 2 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Deferoxamine mesylate 2 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
ampicilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
ampicilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Deferoxamine mesylate 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Deferoxamine mesylate 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
clarithromycine 500 mg, fiole de poudre pour perfusion (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
clarithromycine 500 mg, fiole de poudre pour perfusion (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
ampicilline et floxacilline 250 mg/250 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 2
ampicilline et floxacilline 250 mg/250 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
colistiméthate sodique 500 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
colistiméthate sodique 500 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Amifostine 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Amifostine 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
colistiméthate sodique 1 000 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
colistiméthate sodique 1 000 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
colistiméthate sodique 1 000 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
ceftazidime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
ceftazidime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
pénicilline G 1 200 mg, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
pénicilline G 1 200 mg, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Clarithromycin 250 mg granules for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Clarithromycin 250 mg granules for oral suspension sachet Count of base of active ingredient False un Inferred relationship Some
Amifostine 375 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Amifostine 375 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
complexe hémagglutinine-toxine botulique de type A 500 unités, pour injection (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
complexe hémagglutinine-toxine botulique de type A 500 unités, pour injection (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
pénicilline g 600 mg, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
pénicilline g 600 mg, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Epirubicin hydrochloride 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Epirubicin hydrochloride 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
ceftriaxone 250 mg, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
ceftriaxone 250 mg, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
ceftriaxone 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
ceftriaxone 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
ceftriaxone 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
ceftriaxone 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
ceftriaxone 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
capréomycine 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
capréomycine 1 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
capréomycine 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
cefpirome 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
cefpirome 1 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
cefpirome 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
amoxicilline 250 mg, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
amoxicilline 250 mg, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
cefpirome 2 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
cefpirome 2 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
amoxicilline 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
amoxicilline 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
amoxicilline 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Mitomycin 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Mitomycin 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Fludarabine phosphate 50 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Fludarabine phosphate 50 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
idarubicin hydrochloride 5mg powder for injection solution vial (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
idarubicin hydrochloride 5mg powder for injection solution vial (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Chlorpromazine hydrochloride 5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Ifosfamide 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Ifosfamide 1 g powder for solution for injection vial Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Ifosfamide 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
pantoprazole 40 mg, fiole de poudre pour injection (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
pantoprazole 40 mg, fiole de poudre pour injection (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial Count of base of active ingredient False un Inferred relationship Some
idarubicin hydrochloride 10mg powder for injection solution vial (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
idarubicin hydrochloride 10mg powder for injection solution vial (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Ifosfamide 2 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Ifosfamide 2 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
liothyronine sodique 20 microgrammes, ampoule de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
liothyronine sodique 20 microgrammes, ampoule de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1

Start Previous Page 183 of 217 Next End

This concept is not in any reference sets

Back to Start